Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Electromed, Inc. (ELMD : AMEX)
 
 • Company Description   
Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.

Number of Employees: 132

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.45 Daily Weekly Monthly
20 Day Moving Average: 10,477 shares
Shares Outstanding: 8.53 (millions)
Market Capitalization: $106.24 (millions)
Beta: 0.57
52 Week High: $13.85
52 Week Low: $9.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.35% 6.59%
12 Week 2.47% 10.74%
Year To Date -4.23% 13.44%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
500 SIXTH AVENUE NW
-
NEW PRAGUE,MN 56071
USA
ph: 952-758-9299
fax: 866-758-5077
investorrelations@electromed.com None
 
 • General Corporate Information   
Officers
Kathleen S. Skarvan - Chief Executive Officer and President
Stephen H. Craney - Chairman
Michael J. MacCourt - Chief Financial Officer
Stan K. Erickson - Director
Gregory J. Fluet - Director

Peer Information
Electromed, Inc. (ABMD)
Electromed, Inc. (DMDS)
Electromed, Inc. (CPWY.)
Electromed, Inc. (EQUR)
Electromed, Inc. (ECIA)
Electromed, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 285409108
SIC: 3845
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/23/22
Share - Related Items
Shares Outstanding: 8.53
Most Recent Split Date: (:1)
Beta: 0.57
Market Capitalization: $106.24 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/23/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 47.88
PEG Ratio: -
Price Ratios
Price/Book: 3.12
Price/Cash Flow: 36.17
Price / Sales: 2.67
EPS Growth
vs. Year Ago Period: 133.33%
vs. Previous Quarter: -30.00%
Sales Growth
vs. Year Ago Period: 15.41%
vs. Previous Quarter: -1.04%
ROE
03/31/22 - 6.99
12/31/21 - 5.77
09/30/21 - 6.94
ROA
03/31/22 - 6.10
12/31/21 - 5.06
09/30/21 - 6.12
Current Ratio
03/31/22 - 6.64
12/31/21 - 6.95
09/30/21 - 6.74
Quick Ratio
03/31/22 - 6.22
12/31/21 - 6.57
09/30/21 - 6.32
Operating Margin
03/31/22 - 5.83
12/31/21 - 4.94
09/30/21 - 6.00
Net Margin
03/31/22 - 5.83
12/31/21 - 4.94
09/30/21 - 6.00
Pre-Tax Margin
03/31/22 - 7.90
12/31/21 - 6.57
09/30/21 - 8.06
Book Value
03/31/22 - 3.99
12/31/21 - 3.91
09/30/21 - 3.86
Inventory Turnover
03/31/22 - 4.79
12/31/21 - 4.54
09/30/21 - 3.96
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©